1支架术后面临的问题支架内血栓形成(stent thrombo-sis,ST)和支架内再狭窄(in-stent restenosis,ISR)是支架术后面临最主要问题之一。裸支架能有效降.
基于166个网页-相关网页
1支架术后面临的问题支架内血栓形成(stent thrombo-sis,ST)和支架内再狭窄(in-stent restenosis,ISR)是支架术后面临最主要问题之一。裸支架能有效降.
基于52个网页-相关网页
...再狭窄 [gap=1525]ds】 sirolimus-eluting stent; coronary artery disease; intra-stent thrombosis; in-stent restenosis ...
基于24个网页-相关网页
伴随着支架置入术数量的稳定增长以及罪犯血管损伤的复杂性,支架再狭窄(in-stent restenosis,ISR)的数量的稳步增长[1],发生率近似于10%～30%.
基于24个网页-相关网页
in-stent restenosis isr 支架后再狭窄
in-stent restenosis interventional 支架内再狭窄
coronary artery in-stent restenosis 冠状动脉支架内再狭窄
Conclusion The management of in-stent restenosis in target vessels using a combination of rotational atherectomy and balloon angioplasty is safe and efficient.
结论 冠状动脉旋磨术与球囊扩张联合应用是一种安全的和有效的治疗支架内再狭窄的方法。
参考来源 - 冠状动脉内旋磨术治疗支架内再狭窄 Treatment of in·2,447,543篇论文数据，部分数据来源于NoteExpress
This article reviews the pathology and prevention for in-stent restenosis.
现就支架再狭窄的病理及其防治作一综述。
In-stent restenosis has been significantly reduced by utilization of drug eluting stents.
药物涂层支架的应用显著降低了支架内再狭窄的发生。
In-stent restenosis is the major factor influencing the results of percutaneous coronary intervention.
支架内再狭窄是影响经皮冠状动脉介入治疗疗效的主要原因。
应用推荐